Cellectis (CLLS) Gross Profit (QoQ) (2015 - 2023)
Cellectis (CLLS) Gross Profit (QoQ) (2015 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.67 Bn | 466.88 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.32 Bn | 115.07 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.55 Bn | 34.54 Bn | 959.66 Mn |
| 10 | Cellectis | 285.50 Mn | 99.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 395.75% |
| Sep 30, 2023 | -272.36% |
| Jun 30, 2023 | 163.08% |
| Mar 31, 2023 | -564.29% |
| Dec 31, 2022 | 121.88% |
| Sep 30, 2022 | -119.63% |
| Jun 30, 2022 | 2,956.25% |
| Mar 31, 2022 | 152.46% |
| Dec 31, 2021 | 93.23% |
| Sep 30, 2021 | -55.88% |
| Jun 30, 2021 | 75.33% |
| Mar 31, 2021 | 53.09% |
| Dec 31, 2020 | -204.39% |
| Sep 30, 2020 | 43.94% |
| Jun 30, 2020 | -106.43% |
| Mar 31, 2020 | 3,804.48% |
| Dec 31, 2019 | -129.05% |
| Sep 30, 2019 | 1,155.49% |
| Jun 30, 2019 | -25.11% |
| Mar 31, 2019 | 81.45% |